SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-20-000070
Filing Date
2020-10-02
Accepted
2020-10-02 17:01:56
Documents
1
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160167250309207.html 4  
1 FORM 4 wf-form4_160167250309207.xml 4 6580
  Complete submission text file 0001399529-20-000070.txt   7928
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXCELLA HEALTH INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Aradhye Shreeram (Reporting) CIK: 0001778372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 201221006